Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Dr. Martens plc
  6. News
  7. Summary
    DOCS   GB00BL6NGV24

DR. MARTENS PLC

(DOCS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Dr Martens : Goldman Sachs Improves Dr. Martens Rating To Buy, Ups PT

07/13/2021 | 08:05am EDT


ę MT Newswires 2021
All news about DR. MARTENS PLC
08/02Certain Ordinary Shares of Dr. Martens plc are subject to a Lock-Up Agreement Ending on..
CI
07/29DR MARTENS : Revenue Soars 52% In Fiscal Q1
MT
07/29DR MARTENS : Earnings Flash (DOCS.L) DR. MARTENS Reports Fiscal Q1 Revenue GBP147.3M
MT
07/29Dr. Martens plc Reports Revenue Results for the First Quarter Ended June 30, 2021
CI
07/13DR MARTENS : Goldman Sachs Improves Dr. Martens Rating To Buy, Ups PT
MT
07/12Dr. Martens plc Announces Prior Year Quarterly Revenue Figures for the Year Ending 31 M..
CI
07/01Europe feasts on 'sublime' IPO bonanza in 2021. Is it getting bloated?
RE
06/28DR MARTENS : HSBC Upgrades Dr. Martens To Buy From Hold, Lifts PT
MT
06/21DR MARTENS : RBC Reduces Dr. Martens PT, Keeps Outperform Rating
MT
06/21DR. MARTENS PLC(LSE : DOCS) added to FTSE All-World Index
CI
More news
Analyst Recommendations on DR. MARTENS PLC
More recommendations
Financials
Sales 2022 905 M 1 236 M 1 236 M
Net income 2022 158 M 216 M 216 M
Net Debt 2022 164 M 223 M 223 M
P/E ratio 2022 25,5x
Yield 2022 1,08%
Capitalization 4 030 M 5 499 M 5 504 M
EV / Sales 2022 4,63x
EV / Sales 2023 3,89x
Nbr of Employees 1 897
Free-Float 89,6%
Chart DR. MARTENS PLC
Duration : Period :
Dr. Martens plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. MARTENS PLC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 403,00 GBX
Average target price 519,38 GBX
Spread / Average Target 28,9%
EPS Revisions
Managers and Directors
Kenneth Charles Wilson Chief Executive Officer & Director
Jon William Mortimore Chief Financial Officer & Director
Paul Mason Chairman
Ronald Garricks Chief Information Officer
Geert Raymond Peeters Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
DR. MARTENS PLC0.00%5 511
PUMA SE7.50%17 414
DECKERS OUTDOOR CORPORATION48.53%11 783
CROCS, INC.142.13%9 465
ALPARGATAS S.A.33.50%5 614
RELAXO FOOTWEARS LIMITED42.53%3 927